Meanwhile, several researchers revealed EGCG attenuated EGF-induced FASN expression at protein and mRNA levels, suppressed Akt activation, and blocked the contact of transcription factor Sp-1 with its target gene in breast cancer cells, thus exerting its anti-proliferative pharmacological effects (218). Here, AKT1 is linked to breast carcinoma.